Anacor Pharmaceuticals, Inc. (ANAC) Misses Q1 EPS by 5c

Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) reported Q1 EPS of ($0.48), $0.05 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.42 million versus the consensus estimate of $3.65 million.

For earnings history and earnings-related data on Anacor Pharmaceuticals, Inc. (ANAC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity to acquire Harte Hanks for $5 per share in cash and stock
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c